20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Mesa Laboratories Inc (MLAB) operates in the SCIENTIFIC & TECHNICAL INSTRUMENTS industry and is headquartered in Lakewood, United States with about 717 employees. Its market capitalization is roughly $702 million. In the fiscal year ended 2026-03-31, MLAB reported $249M in revenue and $7M in net income.
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
Interactive charts & full statements → Open the MLAB valuation workbench →
| Income statement | TTM → 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | 2011-03-31 | 2010-03-31 | 2009-03-31 | 2008-03-31 | 2007-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $250M | $249M | $241M | $216M | $219M | $184M | $134M | $118M | $103M | $96M | $94M | $85M | $71M | $53M | $46M | $40M | $33M | $22M | $22M | $20M | $17M |
| Gross Profit | $165M | $158M | $151M | $133M | $134M | $109M | $87M | $65M | $61M | $55M | $53M | $51M | $43M | $32M | $29M | $24M | $20M | $13M | $14M | $13M | $11M |
| Gross Margin % | 66.0% | 63.5% | 62.6% | 61.6% | 61.0% | 59.2% | 65.0% | 55.5% | 59.1% | 56.8% | 56.8% | 60.7% | 60.8% | 60.1% | 62.2% | 59.4% | 59.6% | 60.2% | 64.2% | 65.7% | 63.2% |
| Operating Income (EBIT) | $22M | $19M | $16M | ($272M) | $3M | $5M | $12M | $8M | $10M | $2M | $16M | $16M | $16M | $12M | $13M | $12M | $10M | $7M | $8M | $7M | $6M |
| Operating Margin % | 9.0% | 7.4% | 6.8% | -125.8% | 1.5% | 2.5% | 9.2% | 6.7% | 9.5% | 2.3% | 17.4% | 19.3% | 22.2% | 22.4% | 28.2% | 31.5% | 30.0% | 33.6% | 35.3% | 36.1% | 32.8% |
| Net Income | $5M | $7M | ($2M) | ($254M) | $1M | $2M | $3M | $2M | $7M | ($3M) | $11M | $11M | $10M | $9M | $8M | $8M | $6M | $5M | $5M | $5M | $4M |
| Net Margin % | 1.9% | 2.7% | -0.8% | -117.6% | 0.4% | 1.0% | 2.4% | 1.5% | 7.3% | -3.1% | 11.9% | 13.2% | 13.4% | 17.1% | 18.2% | 20.0% | 18.8% | 21.8% | 22.2% | 23.6% | 23.0% |
| EBITDA | $41M | $35M | $42M | ($238M) | $38M | $33M | $28M | $22M | $35M | $10M | $25M | $23M | $22M | $16M | $17M | $15M | $12M | $8M | $8M | $8M | $6M |
| Earnings Per Share (EPS) | $0.85 | $1.21 | $-0.36 | $-47.20 | $0.17 | $0.35 | $0.64 | $0.41 | $1.86 | $-0.79 | $2.91 | $2.97 | $2.63 | $2.49 | $2.35 | $2.29 | $1.86 | $1.45 | $1.48 | $1.41 | $1.22 |
| Shares Outstanding (M) | 6M | 6M | 5M | 5M | 5M | 5M | 5M | 4M | 4M | 4M | 4M | 4M | 4M | 4M | 4M | 3M | 3M | 3M | 3M | 3M | 3M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $60M | $64M | $65M | $61M | $60M | $62M | $63M | $58M |
| Gross Profit | $39M | $47M | $42M | $37M | $32M | $38M | $40M | $35M |
| Gross Margin % | 64.9% | 73.2% | 64.2% | 61.5% | 54.6% | 61.8% | 63.3% | 61.3% |
| Operating Income (EBIT) | $7M | $3M | $8M | $5M | $3M | $1M | $6M | $4M |
| Operating Margin % | 11.7% | 4.3% | 12.2% | 7.8% | 5.1% | 2.4% | 9.2% | 6.1% |
| Net Income | $3M | ($4M) | $4M | $2M | $5M | ($7M) | ($2M) | $3M |
| Net Margin % | 4.7% | -6.5% | 5.6% | 4.1% | 8.0% | -11.5% | -2.7% | 5.9% |
| EBITDA | $12M | $4M | $13M | $11M | $15M | $10M | $6M | $13M |
| Earnings Per Share (EPS) | $0.49 | $-0.75 | $0.65 | $0.45 | $0.85 | $-1.31 | $-0.31 | $0.63 |
| Shares Outstanding (M) | 6M | 6M | 6M | 6M | 6M | 5M | 5M | 5M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | 2011-03-31 | 2010-03-31 | 2009-03-31 | 2008-03-31 | 2007-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $56M | $43M | $47M | $44M | $28M | $39M | $37M | $27M | $31M | $25M | $8M | $17M | $11M | $12M | $11M | $12M | $9M | $6M | $5M | $5M | $4M |
| Capital Expenditures (CapEx) | $5M | $3M | $4M | $3M | $5M | $4M | $2M | $1M | $1M | $3M | $12M | $8M | $3M | $1M | $1M | $1M | $3M | $3M | $1M | $0M | $2M |
| Free Cash Flow (FCF) | $50M | $40M | $42M | $42M | $23M | $35M | $35M | $25M | $29M | $22M | ($4M) | $9M | $8M | $11M | $10M | $12M | $6M | $3M | $4M | $4M | $2M |
| FCF Margin % | 20.2% | 15.9% | 17.6% | 19.2% | 10.7% | 18.9% | 26.2% | 21.3% | 28.4% | 22.9% | -4.1% | 10.8% | 11.2% | 21.5% | 22.6% | 29.8% | 19.0% | 12.8% | 20.4% | 21.8% | 13.1% |
| Dividends Paid | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $15M | $14M | $19M | $8M | $2M | $13M | $18M | $5M |
| Capital Expenditures (CapEx) | $1M | $3M | $1M | $1M | $1M | $1M | $1M | $2M |
| Free Cash Flow (FCF) | $14M | $11M | $18M | $7M | $1M | $12M | $18M | $3M |
| FCF Margin % | 23.6% | 17.5% | 27.7% | 11.7% | 1.5% | 18.8% | 28.1% | 6.0% |
| Dividends Paid | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | 2011-03-31 | 2010-03-31 | 2009-03-31 | 2008-03-31 | 2007-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $419M | $428M | $433M | $447M | $662M | $707M | $601M | $420M | $157M | $164M | $172M | $161M | $117M | $98M | $66M | $51M | $51M | $34M | $30M | $26M | $22M |
| Cash & Cash Equivalents | $31M | $27M | $27M | $28M | $33M | $49M | $264M | $81M | $10M | $5M | $6M | $6M | $2M | $6M | $4M | $7M | $4M | $10M | $9M | $6M | $3M |
| Total Liabilities | $230M | $242M | $274M | $301M | $268M | $314M | $195M | $200M | $45M | $65M | $74M | $76M | $44M | $33M | $13M | $7M | $15M | $2M | $2M | $2M | $2M |
| Total Debt (Short + Long-Term) | $145M | $155M | $181M | $225M | $186M | $221M | $147M | $141M | $23M | $46M | $55M | $45M | $26M | $33M | $4M | $0M | $6M | $0M | $0M | $0M | $0M |
| Total Shareholders' Equity | $189M | $186M | $160M | $145M | $393M | $394M | $406M | $220M | $111M | $99M | $98M | $85M | $73M | $64M | $53M | $44M | $36M | $31M | $28M | $24M | $21M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MLAB viewer.
About TickerBase · Data methodology & sources · Privacy · Terms